Etid klinik pou Sipwa nan Georgia
36 etid pou Sipwa ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
- Atlanta20 etid
- Johns Creek14 etid
- South Fulton11 etid
- Roswell10 etid
- Sandy Springs5 etid
- Columbus4 etid
- Savannah3 etid
Tèks ofisyèl etid la (Anglè)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Children's Healthcare Atlanta, Atlanta
- Columbus Research Foundation, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- ak 1 plis
Ap rekriteFaz 3
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Hope Clin Res & Wellness, Conyers
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Conquest Research, Atlanta
- Eastside Bariatric and Gen Surg, Snellville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- SKY Clinical Research Network Group-Brown, Atlanta
- HOPE Clinical Research & Wellness, Conyers
- Care Access - Dalton Walmart, Dalton
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
- Research Site, Woodstock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- The Jones Center Clinical Research, Macon
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- East Coast Institute for Research LLC at Canton Georgia, Canton
- The Jones Center Clinical Research, Macon
- Velocity Clinical Research - Savannah, Savannah
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Orita Clinical Research, Decatur
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- Clinical Research Atlanta, Stockbridge
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Woodstock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Teak Research Consults - Dunwoody, Dunwoody
- Center for Advanced Research & Education, Gainesville
- Clinical Research Atlanta, Stockbridge
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Teak Research Consults, Lawrenceville
- EBGS Clinical Research Center, Snellville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Canton
- AURORA-2 Clinical Site, Decatur
- AURORA-2 Clinical Site, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Canton
- AURORA-1 Clinical Site, Decatur
- AURORA-1 Clinical Site, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centricity Research Columbus Georgia Multispecialty, Columbus
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
- Physicians Research Associates, Lawrenceville
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Atlanta
- ACCOMPLISH-2 Research Site, Columbus
- ACCOMPLISH-2 Research Site, Lawrenceville
- ak 2 plis
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Conquest Research, Atlanta
- Physicians Research Associates, Lawrenceville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07571005Intermittent Cottonseed Oil Consumption
- University of Georgia, Athens
Ap rekriteVolontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT07246408Cottonseed Oil Versus Matched PUFA Effects
- University of Georgia, Athens
Ap rekriteVolontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT06382298AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- NeuroTrials Research, Inc., Atlanta
- Physicians Research Associates, Lawrenceville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07571109A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- SKY Clinical Research Network Group-Brown, Atlanta
- Teak Research Consults, Lawrenceville
- AGILE Clinical Research Trials, LLC, Sandy Springs
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Hope Clin Res & Wellness, Conyers
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07745504A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Southeast Research Specialists, Douglasville
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Decatur
- Kailera Clinical Site, Lilburn
- Kailera Clinical Site, Marietta
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Lilburn
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Center for Advanced Research and Education, Gainesville
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
- Georgia State University, Atlanta
Ap rekrite
Laj 45 a 65 · Tout sèks · Mizajou Sep 2, 2026 · NCT06735599Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
- Georgia State University, Atlanta
Ap rekrite
Laj 20 a 65 · Fanm · Mizajou Sep 2, 2026 · NCT06735651Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Nsc Research, Johns Creek
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
- North Georgia Clinical Research, Woodstock
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Buford
- ACCOMPLISH-1 Research Site, Columbus
- ACCOMPLISH-1 Research Site, Lawrenceville
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
- Kennesaw State Universityh, Kennesaw
Ap rekriteVolontè an sante akeyi
Laj 20 ak plis · Tout sèks · Mizajou Oct 27, 2025 · NCT07221279Lifestyle Intervention for Healthy Change
- Augusta University, Augusta
Ap rekriteVolontè an sante akeyi
Laj 18 a 40 · Tout sèks · Mizajou Feb 19, 2025 · NCT05956574Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.